Parkinson's Disease Drug Carbidopa has Anticancer potential
Highlights:
- Carbidopa, a drug used to treat Parkinson's disease (PD) has been found to have significant anticancer properties in this current study
- Many of the current chemotherapeutic agents are associated with severe unwanted and long lasting side effects
- Since Carbidopa is FDA approved, and found to be a safe drug, further studies to investigate its anticancer effect merit consideration
Anti-Parkinson's disease drug Carbidopa found to have anti-cancer effects and could emerge as potential anticancer drug in the future, according to a recent study at the Texas Tech University Health Sciences Center in the USA.
The findings of the study appear in the Biochemical Journal, and could probably explain why the incidence of several cancers, except melanoma is lower in persons with Parkinson's disease.
‘Carbidopa is an FDA approved drug used in Parkinson�s disease and further studies to assess its anticancer properties should be carried out to establish its role as an anticancer agent.’
"Carbidopa is an FDA-approved drug for treating Parkinson's disease. Hence, clinical trials can be conducted right away to evaluate its efficacy in humans as an anticancer drug," explained lead study author Dr Yangzom Bhutia from Texas Tech University Health Sciences Center in the USA.
Carbidopa As Anticancer Agent - The Advantages
Carbidopa is an FDA approved drug to treat Parkinson's disease. It has been proven to be safe and well tolerated. Thus it would be relatively easier to explore the role of this drug to treat cancer, while significantly reducing the time, effort and money that would otherwise be required to be spent in investigating a totally new drug.Professor Aideen Sullivan from the University College Cork is a Parkinson's disease expert who was not involved in the research. When asked about the current study, she commented: "With increasing interest in the re-purposing of drugs, to reduce costs and time needed to get a drug to market, it is timely for investigators to explore the potential anticancer properties of anti-Parkinson's therapies."
(https:www.eurekalert.org/emb_releases/2017-09/bs-pdd092617.php)Source: Medindia
Cite this Article ⇣⇡
Please use one of the following formats to cite this article in your essay, paper or report:
-
APA
Dr. Lakshmi Venkataraman. (2017, September 30). Parkinson's Disease Drug Carbidopa has Anticancer potential. Medindia. Retrieved on Nov 19, 2024 from https://www.medindia.net/news/healthinfocus/anticancer-effect-of-parkinsons-disease-drug-carbidopa-identified-173398-1.htm.
MLA
Dr. Lakshmi Venkataraman. "Parkinson's Disease Drug Carbidopa has Anticancer potential". Medindia. Nov 19, 2024. <https://www.medindia.net/news/healthinfocus/anticancer-effect-of-parkinsons-disease-drug-carbidopa-identified-173398-1.htm>.
Chicago
Dr. Lakshmi Venkataraman. "Parkinson's Disease Drug Carbidopa has Anticancer potential". Medindia. https://www.medindia.net/news/healthinfocus/anticancer-effect-of-parkinsons-disease-drug-carbidopa-identified-173398-1.htm. (accessed Nov 19, 2024).
Harvard
Dr. Lakshmi Venkataraman. 2017. Parkinson's Disease Drug Carbidopa has Anticancer potential. Medindia, viewed Nov 19, 2024, https://www.medindia.net/news/healthinfocus/anticancer-effect-of-parkinsons-disease-drug-carbidopa-identified-173398-1.htm.
Cite this Article ⇣⇡
Please use one of the following formats to cite this article in your essay, paper or report:
-
APA
Dr. Lakshmi Venkataraman. (2017, September 30). Parkinson's Disease Drug Carbidopa has Anticancer potential. Medindia. Retrieved on Nov 19, 2024 from https://www.medindia.net/news/healthinfocus/anticancer-effect-of-parkinsons-disease-drug-carbidopa-identified-173398-1.htm.
MLA
Dr. Lakshmi Venkataraman. "Parkinson's Disease Drug Carbidopa has Anticancer potential". Medindia. Nov 19, 2024. <https://www.medindia.net/news/healthinfocus/anticancer-effect-of-parkinsons-disease-drug-carbidopa-identified-173398-1.htm>.
Chicago
Dr. Lakshmi Venkataraman. "Parkinson's Disease Drug Carbidopa has Anticancer potential". Medindia. https://www.medindia.net/news/healthinfocus/anticancer-effect-of-parkinsons-disease-drug-carbidopa-identified-173398-1.htm. (accessed Nov 19, 2024).
Harvard
Dr. Lakshmi Venkataraman. 2017. Parkinson's Disease Drug Carbidopa has Anticancer potential. Medindia, viewed Nov 19, 2024, https://www.medindia.net/news/healthinfocus/anticancer-effect-of-parkinsons-disease-drug-carbidopa-identified-173398-1.htm.